Shares of Vitamin Shoppe (VSI +9.1%) soar after the company beats on both lines of its Q1...

|About: Vitamin Shoppe, Inc. (VSI)|By:, SA News Editor

Shares of Vitamin Shoppe (VSI +9.1%) soar after the company beats on both lines of its Q1 report. CEO Tony Truesdale says on a CC (webcast) that the recent FDA warning on DMAA won't have a material impact on earnings, as the company plans to keep products with the supplements on its shelves until the FDA acts.